Advancing Personalized Cancer Care: Regulatory Strategies for Health Canada and FDA Approval of mRNA Vaccines.
Bibliographic record
Abstract
Health Canada has recognized mRNA technology’s potential, building on its rapid deployment during the COVID-19 pandemic to explore its role in cancer care (Health Canada, 2023). This adaptability positions mRNA as a cornerstone for innovative treatments, aligning with Canada’s emphasis on advancing biologic therapies to address unmet medical needs. Its transient nature ensures safety by avoiding DNA alteration, a priority under Canadian regulatory frameworks. The FDA has similarly embraced mRNA’s success in infectious diseases, catalyzing its oncology applications with a focus on specificity and reduced long term genetic risks. This article outlines a regulatory strategy for securing approval from Health Canada and the FDA, detailing classification, clinical trials, and agency interactions to balance innovation with safety in precision oncology.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.049 | 0.071 |
| Meta-epidemiology (narrow) | 0.001 | 0.001 |
| Meta-epidemiology (broad) | 0.001 | 0.002 |
| Bibliometrics | 0.003 | 0.003 |
| Science and technology studies | 0.008 | 0.011 |
| Scholarly communication | 0.014 | 0.008 |
| Open science | 0.006 | 0.007 |
| Research integrity | 0.029 | 0.021 |
| Insufficient payload (model declined to judge) | 0.013 | 0.003 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".